About Panorama

HCP header

Why Panorama?

Panorama® is a non-invasive prenatal screening test (NIPT) for fetal chromosomal abnormalities. The test uses advanced bioinformatics technology to evaluate fetal DNA (of placental origin) in maternal blood.

Only Panorama can distinguish between fetal and maternal DNA in the mother's blood to give you and your patient vital information about the fetus. With a comprehensive panel of chromosomal aneuploidies and microdeletions, Panorama delivers the most accurate results of any screening test, as early as 9 weeks of gestation, to help you manage your patient's pregnancy.


Meet Your Local Clinical Specialist


The Most Accurate

Panorama provides risk assessment on more clinically significant chromosome abnormalities than other NIPTs. Every Panorama report includes a personalized risk score for trisomy 21, 18, 13, and monosomy X.

In addition, Panorama offers a panel of microdeletion syndromes. These syndromes were chosen with care to provide relevant information for conditions that are common, can be severe, are under-diagnosed prenatally, and may benefit from early intervention after delivery.